Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $114.2M |
| Sales growthchange from the year before | +631.8% |
| Gross marginshare of sales left after the direct cost of what it sells | -125.9% |
| Operating marginshare of sales left after running the business | -227.0% |
| Net marginshare of sales kept as profit | -849.1% |
| Free-cash-flow marginspare cash generated per $100 of sales | -232.0% |
| Return on equityprofit vs. shareholders' accounting value | n/m |
| Debt / equitydebt vs. shareholders' accounting value | n/m |
| Change in share countnegative = the company is buying back its shares | +23.0% |
3 insiders sold $1.0M (45% under pre-arranged plans) on the open market.
| Kroeker NathanChief Commercial Officer | Sold (plan)Jul 28 | 110,417 shat $3.36 · $371K |
| Puri SumeetChief Accounting Officer | Sold (plan)Jul 28 | 29,167 shat $3.36 · $98K |
| Mastrangelo JoeChief Executive Officer · Director | SoldJul 27 | 159,154 shat $3.61 · $575K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy